Amarin Corp Plc (AMRN)

[concapk]

Reloc:

Thanks for the summary... this case goes to court whereas the defendants will seek to sell generic brand for high tri's ( marine indication ) ONLY , with labeling to reduce high tri's in a short duration .... since having high tri's is a chronic problem their labeling can't say they are for the long term...

Gererics can not state on the label that they help with Other Health Benefits,but Vascepa labeling can... they can not state with /without statin use...

AMARINS patents are valid .... the Generics did not invalidate them.... any concession will be limited to the GENERICS ( Marine Indication only ) when the case proceeds Jan 13,2020... this does not allow the Generics to use this against Amarin for the Reduce'it results....